Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Hackensack, New Jersey

Phase 1 cancer trials in Hackensack, NJ

40 Phase 1 cancer studies are recruiting participants at sites in Hackensack as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Hackensack at a glance

  • 40 studies are recruiting at a site in Hackensack.
  • By phase: Phase 1 (19), Phase 1/2 (21).
  • By sponsor: industry (37), university, hospital or other (3).
  • By research area: Lung Cancer (21), Breast Cancer (9), Lymphoma (8), Prostate Cancer (2).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Hackensack

Basic details from each study's public record (the 30 most recently updated of 40). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Hackensack University Medical Center
    Registry record
    NCT07488676 · updated
  2. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    John Theurer Cancer Center at Hackensack UMC
    Registry record
    NCT06586957 · updated
  3. A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center
    Registry record
    NCT07287995 · updated
  4. A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center
    Registry record
    NCT06618287 · updated
  5. A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Normunity AccelCo, Inc.
    Study site
    Normunity Investigational Site
    Registry record
    NCT07182149 · updated
  6. A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    John Theurer Cancer Center
    Registry record
    NCT04895709 · updated
  7. Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Vironexis Biotherapeutics Inc.
    Study site
    Hackensack Medical Center
    Registry record
    NCT07192432 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Hackensack, NJ on ClinicalTrials.gov.

Lung cancer studies recruiting in Hackensack

  1. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    John Theurer Cancer Center-Hackensack
    Registry record
    NCT07080242 · updated
  2. A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center ( Site 0101)
    Registry record
    NCT07227597 · updated
  3. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center
    Registry record
    NCT07397338 · updated
  4. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    John Theurer Cancer Center at Hackensack UMC
    Registry record
    NCT07542704 · updated
  5. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    Hackensack University Medical Center
    Registry record
    NCT07094204 · updated
  6. A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alentis Therapeutics AG
    Study site
    Hackensack University Medical Center
    Registry record
    NCT06747585 · updated
  7. A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Zai Lab (Shanghai) Co., Ltd.
    Study site
    Hackensack University Medical Center
    Registry record
    NCT06179069 · updated
  8. A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Moonlight Bio, Inc
    Study site
    Hackensack University Medical Center
    Registry record
    NCT07488923 · updated
  9. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Hackensack University Medical Center · John Theurer Cancer Center at Hackensack University Medical Center · Newman Street Imaging
    Registry record
    NCT07227298 · updated
  10. A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103)
    Registry record
    NCT06780137 · updated
  11. A Study of ZW251 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Zymeworks BC Inc.
    Study site
    Hackensack University Medical Center
    Registry record
    NCT07164313 · updated
  12. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #105
    Registry record
    NCT05176483 · updated
  13. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Study site
    John Theurer Cancer Center At Hackensack Umc
    Registry record
    NCT06362252 · updated
  14. A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    John Theurer Cancer Center at Hackensack UMC
    Registry record
    NCT06892548 · updated
  15. Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Whitehawk Therapeutics, Inc.
    Study site
    Hackensack University Medical Center - John Theurer Cancer Center
    Registry record
    NCT07444814 · updated
  16. A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center
    Registry record
    NCT06764771 · updated
  17. A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Hackensack University Medical Center
    Registry record
    NCT06179160 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Hackensack, NJ on ClinicalTrials.gov.

Prostate cancer studies recruiting in Hackensack

  1. A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Regeneron Pharmaceuticals
    Study site
    John Theurer Cancer Center
    Registry record
    NCT07543055 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Hackensack, NJ on ClinicalTrials.gov.

Lymphoma studies recruiting in Hackensack

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Hackensack University Medical Center
    Registry record
    NCT04726241 · updated
  2. A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06564038 · updated
  3. A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06542250 · updated
  4. A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

    • Phase 1
    • Ages 12 to 78
    • All sexes
    Sponsor
    Orca Biosystems, Inc.
    Study site
    John Theurer Cancer Center at Hackensack University Medical Center
    Registry record
    NCT03802695 · updated
  5. Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Lyell Immunopharma, Inc.
    Study site
    John Theurer Cancer Center Hackensack University Medical Center
    Registry record
    NCT05826535 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Hackensack, NJ on ClinicalTrials.gov.

Ask about studies near Hackensack

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call